Cargando…
N-Acetylaspartate Drives Oligodendroglial Differentiation via Histone Deacetylase Activation
An unmet clinical goal in demyelinating pathologies is to restore the myelin sheath prior to neural degeneration. N-acetylaspartate (NAA) is an acetylated derivative form of aspartate, abundant in the healthy brain but severely reduced during traumatic brain injury and in patients with neurodegenera...
Autores principales: | Dominicis, Alessandra, Del Giovane, Alice, Torreggiani, Matteo, Recchia, Antonella Damiana, Ciccarone, Fabio, Ciriolo, Maria Rosa, Ragnini-Wilson, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378218/ https://www.ncbi.nlm.nih.gov/pubmed/37508525 http://dx.doi.org/10.3390/cells12141861 |
Ejemplares similares
-
Smoothened/AMP-Activated Protein Kinase Signaling in Oligodendroglial Cell Maturation
por: Del Giovane, Alice, et al.
Publicado: (2022) -
Targeting Smoothened as a New Frontier in the Functional Recovery of Central Nervous System Demyelinating Pathologies
por: Del Giovane, Alice, et al.
Publicado: (2018) -
The Current Challenges for Drug Discovery in CNS Remyelination
por: Balestri, Sonia, et al.
Publicado: (2021) -
N-Acetylaspartate Metabolism Outside the Brain: Lipogenesis, Histone Acetylation, and Cancer
por: Bogner-Strauss, Juliane G.
Publicado: (2017) -
Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery
por: Daniele, Giuseppe, et al.
Publicado: (2020)